Pfizer Launches "More Than Cancer" Campaign to Promote Inclusive Cancer Care for LGBTIQ+ Patients

A new campaign by Pfizer and OUTpatients aims to encourage UK healthcare professionals to look beyond the diagnosis and see patients as whole individuals, rather than just cancer patients. The "More Than Cancer" campaign, launched this week, urges HCPs to recognize and respect sexual orientation and gender identity, creating a safe and inclusive environment for LGBTIQ+ patients. According to a report, LGBTIQ+ individuals may face higher cancer risks and navigate significant barriers when accessing healthcare.

Key Takeaways:

• The "More Than Cancer" campaign is a collaboration between Pfizer and OUTpatients to promote inclusive cancer care for LGBTIQ+ patients.
• The campaign encourages UK HCPs to look beyond the diagnosis and recognize and respect patients' sexual orientation and gender identity.
• LGBTIQ+ individuals may face higher cancer risks due to higher prevalence of smoking, heavy alcohol use, and cancer-causing infections like HIV and hepatitis C.
• Significant barriers exist for LGBTIQ+ patients when navigating the healthcare system, including the presumption-of-care gap.
• Less than half of trans men are up to date on recommended colorectal cancer screenings due to fears of denial of care.

Statistics:

• The 2024 report by the American Cancer Society highlights the increased risk of cancer among LGBTIQ+ individuals due to higher prevalence of smoking and heavy alcohol use.
• LGBTIQ+ individuals face increased risks due to higher-than-average rates of certain cancer-causing infections such as HIV and hepatitis C.
• Less than half of trans men are up to date on recommended colorectal cancer screenings.
• The presumption-of-care gap, or fear of denial of care, results in significant barriers for LGBTIQ+ patients when navigating the healthcare system.

Sources:

• "Hear Me Out" campaign website
• OUTpatients
• Pfizer/LINKEDIN
• 2024 Report by the American Cancer Society